Contemporary Management of HIV 2021

Download All
Gain expert insights on the latest data supporting contemporary HIV prevention and HIV treatment across settings, including patients who are newly diagnosed, virologically suppressed, or experiencing virologic failure with resistance, along with new and emerging ART strategies.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Roger Bedimo, MD, MS, FACP
Michelle S. Cespedes, MD, MS
Eric S. Daar, MD
Jason Halperin, MD, MPH
W. David Hardy, MD
Gregory Huhn, MD, MPHTM
Princy N. Kumar, MD, FIDSA, MACP
Daniel R. Kuritzkes, MD
Paul E. Sax, MD
Renslow Sherer, MD
William R. Short, MD, MPH, AAHIVS
Babafemi Taiwo, MBBS
David A. Wohl, MD

New Data From CROI 2021

Download this expert-authored slideset to review the most clinically relevant new data presented at CROI 2021 covering a wide range of HIV management topics, including HIV PrEP strategies; ART in pregnancy, the postpartum period, and adolescence; current and investigational ART; and coinfections.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP Daniel R. Kuritzkes, MD
Released: April 9, 2021

Watch this dynamic video module in which CCO’s expert faculty, Drs. Eric Daar and Renslow Sherer, present and discuss with one another some of the most clinically relevant new data presented at CROI 2021, including results from studies on HIV PrEP strategies, COVID-19 outcomes among PWH, ART during pregnancy/postpartum period, long-term use of current ART, and novel ART strategies in late-phase development.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD Renslow Sherer, MD
Released: May 10, 2021

Listen to expert insights from Daniel R. Kuritzkes, MD, and Michelle S. Cespedes, MD, MS, on updates from virtual CROI 2021, including new data on first-line ART and results from the ATLAS 2M and CAPELLA trials.

Michelle S. Cespedes, MD, MS Daniel R. Kuritzkes, MD Released: May 18, 2021

ART for Complex Cases

Download this expert-authored slideset to review treatment strategies for complex HIV cases; topics include managing heavily treatment-experienced patients, modifying ART in patients with underlying ARV resistance, and considerations for first-line ART selection in patients with obesity.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
Released: September 1, 2020

Gain expert insights on treatment strategies for complex HIV cases; topics include managing ART in heavily treatment-experienced patients, modifying ART in patients with underlying ARV resistance, and considerations for first-line ART selection in patients with obesity.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD Jason Halperin, MD, MPH
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: December 8, 2020 Expired: December 7, 2021

Emerging Approaches to Optimize ART

Download this expert-authored slideset to consider important clinical questions related to first-line ART, long-acting antiretroviral drugs, and 2-drug regimens for ART, with an emphasis on the role of new and emerging strategies.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
David A. Wohl, MD
Released: March 17, 2021

Gain expert insights on important clinical questions related to first-line ART, switch strategies for patients with virologic suppression, and use of antiretroviral drugs to prevent HIV infection, with an emphasis on the role of new and emerging strategies.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Daniel R. Kuritzkes, MD Paul E. Sax, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: December 30, 2020 Expired: December 29, 2021

Frontiers in HIV Prevention

Download this expert-authored slideset reviewing the latest data on HIV prevention, including PrEP uptake, current PrEP options, and next-generation PrEP options.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Gregory Huhn, MD, MPHTM
Released: March 3, 2021

Listen to expert insights from W. David Hardy, MD, on current options for pre-exposure prophylaxis and exciting new data on next-generation HIV prevention.

W. David Hardy, MD Released: June 2, 2021

Heavily Treatment-Experienced Patients

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure, current management options for patients with multiclass drug resistance experiencing treatment failure, and considerations for switching ART in patients with underlying resistance.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Eric S. Daar, MD
Released: March 3, 2021

Gain expert insights on treatment strategies for heavily treatment–experienced patients with HIV. Topics include assessment of virologic failure, current treatment options for patients with multiclass drug resistance, and guidance on selecting the next line of therapy for patients experiencing virologic failure due to resistance.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Roger Bedimo, MD, MS, FACP Eric S. Daar, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: December 22, 2020 Expired: December 21, 2021

Individualizing First line ART

Listen to expert insights from William R. Short, MD, MPH, AAHIVS, on optimizing initial antiretroviral therapy for treatment-naive patients with HIV.

William R. Short, MD, MPH, AAHIVS Released: May 7, 2021

Listen to expert insights from David A. Wohl, MD, on initiating antiretroviral therapy for a treatment-naive patient with HIV, HBV, and obesity.

David A. Wohl, MD Released: June 15, 2021

Download this expert-authored slideset to review national guidelines, key study data, and individual considerations for optimizing the use of current ART regimens as initial HIV treatment and in switch strategies for patients with viral suppression who require a change in therapy.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Babafemi Taiwo, MBBS
Released: July 6, 2020

Download this expert-authored slideset to review national guidelines, key study data, and individual considerations for individualizing first-line ART regimens to treat HIV.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Daniel R. Kuritzkes, MD
Released: February 4, 2021

Modifying ART in Virologically Suppressed Patients

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure, current management options for patients with multiclass drug resistance experiencing treatment failure, and considerations for switching ART in patients with underlying resistance.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Paul E. Sax, MD
Released: March 2, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue